Compumedics Ltd
ASX:CMP

Watchlist Manager
Compumedics Ltd Logo
Compumedics Ltd
ASX:CMP
Watchlist
Price: 0.385 AUD 2.67% Market Closed
Market Cap: 76.9m AUD

Compumedics Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Compumedics Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Compumedics Ltd
ASX:CMP
Cash from Operating Activities
AU$2m
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-1%
Somnomed Ltd
ASX:SOM
Cash from Operating Activities
AU$7.8m
CAGR 3-Years
61%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cochlear Ltd
ASX:COH
Cash from Operating Activities
AU$237.6m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
2%
Optiscan Imaging Ltd
ASX:OIL
Cash from Operating Activities
-AU$6.2m
CAGR 3-Years
-17%
CAGR 5-Years
-35%
CAGR 10-Years
-16%
Austco Healthcare Ltd
ASX:AHC
Cash from Operating Activities
AU$13.4m
CAGR 3-Years
90%
CAGR 5-Years
32%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Cash from Operating Activities
-AU$7.8m
CAGR 3-Years
-27%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
No Stocks Found

Compumedics Ltd
Glance View

Market Cap
74m AUD
Industry
Health Care

Compumedics Ltd. is engaged in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. The firm is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The firm sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The firm sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The firm product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.

CMP Intrinsic Value
0.562 AUD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Compumedics Ltd's Cash from Operating Activities?
Cash from Operating Activities
2m AUD

Based on the financial report for Jun 30, 2025, Compumedics Ltd's Cash from Operating Activities amounts to 2m AUD.

What is Compumedics Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-1%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for Compumedics Ltd have been -15% over the past three years , -18% over the past five years , and -1% over the past ten years .

Back to Top